| NCT ID | NCT04992871 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Bern |
| Condition | Cerebral Palsy |
| Study Type | OBSERVATIONAL |
| Enrollment | 15,000 participants |
| Start Date | 2017-06-19 |
| Primary Completion | 2071-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 15,000 participants in total. It began in 2017-06-19 with a primary completion date of 2071-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Swiss-CP-Reg is a national patient registry that collects information on diagnosis, symptoms, treatment and follow-up of patients with cerebral palsy (CP) in Switzerland. It was first implemented in 2017 in the paediatric clinics in Basel, Bellinzona, Bern, Geneva, Lausanne, St. Gallen and Zurich. It is currently extended to all Swiss clinics and medical practices and adults will be invited to join the register in the coming years. The registry provides data for national and international monitoring and research. It supports research on CP in Switzerland and the exchange of knowledge between clinicians, researchers and therapists, with the goal to improve the treatment of children and adults with CP and optimizing their health and quality of life.
Eligibility Criteria
Inclusion Criteria: * Who were diagnosed with CP, confirmation of the diagnosis at the age of 5 years is required * Who are born, treated for CP or living in Switzerland, and * Who gave informed consent Exclusion Criteria: * Pure muscular hypotonia * Neurometabolic diseases (e.g. neuronal storage diseases, leukodystrophies) * Other progressive neurological diseases (e.g. spinocerebellar ataxias, hereditary spastic paraplegia, Rett syndrome, epileptic encephalopathy)
Contact & Investigator
Claudia E Kuehni, Prof. MD
PRINCIPAL INVESTIGATOR
Institute of Social and Preventive Medicine (ISPM), University of Bern
Frequently Asked Questions
Who can join the NCT04992871 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04992871 currently recruiting?
Yes, NCT04992871 is actively recruiting participants. Contact the research team at swiss-cp-reg.ispm@unibe.ch for enrollment information.
Where is the NCT04992871 trial being conducted?
This trial is being conducted at Aarau, Switzerland, Basel, Switzerland, Bellinzona, Switzerland, Bern, Switzerland and 8 additional locations.
Who is sponsoring the NCT04992871 clinical trial?
NCT04992871 is sponsored by University of Bern. The principal investigator is Claudia E Kuehni, Prof. MD at Institute of Social and Preventive Medicine (ISPM), University of Bern. The trial plans to enroll 15,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.